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Abstract  
 
Dual modality contrast agents, such as radiolabelled magnetic nanoparticles, are promising 
candidates for a number of diagnostic applications, since they combine two complementing 
imaging modalities, namely photon emission computed tomography (SPECT) and magnetic 
resonance imaging (MRI). The benefit of such combination lies on the ability to interpret more 
accurately abnormalities in vivo, by integrating the high sensitivity of SPECT with the superb 
spatial resolution and anatomical information provided by MRI [1]. Superparamagnetic iron 
oxide nanoparticles (SPION) have been extensively studied as MRI contrast agents [2]. SPIONs 
need to be coated in order to allow formulation in aqueous solutions and to increase in vivo 
stability [3].  
Dextrin nanomagnetogels consists on superparamagnetic iron oxide nanoparticles (γ-Fe2O3) 
stabilized within hydrophobized-dextrin nanogel (scheme 1). The nanomagnetogel formulation, 
with about 4 mM of iron and a diameter of 100 nm, presents relevant features such as 
superparamagnetic behaviour, high stability, narrow size distribution and potential for magnetic 
guidance to target areas by means of an external magnetic field [4]. The functionalization of the 
dextrin nanomagnetogel with a DOTA-monoamide ω-thiol metal chelator and radiolabelling with 
111In were used to ascertain its in vivo stability and behavior (blood clearance rate and organ 
distribution) after intravenous administration in mice model. The surface modification of the 
nanomagnetogel with PEG 5,000 was accomplished in an attempt to escape the phagocytic 
system. The unloaded radiolabeled dextrin nanogel (around 30 nm) showed lower uptake in the 
liver, spleen and kidneys than the nanomagnetogel loaded with SPIONs (around 110 nm). This 
difference in biodistribution profile can be ascribed to the differences in the particle size. 
Nanomagnetogel pegylation resulted in lower liver and spleen accumulation. The blood half-life 
obtained was approximately 4 hours for all formulations. A good correlation between the amount 
of polymer (quantified through radioactivity) and the amount of iron (ICP measurement) in the 
spleen was observed, indicating that leakage of iron from the nanomagnetogels after 
intravenous administration was negligible. The pilot imaging study demonstrated good 
performance of dextrin nanomagnetogels as dual modality imaging (MRI and SPECT) 
bioprobes as expected by the high transverse relaxivity (215-248 mM-1s-1) obtained in vitro, 
higher than those of commercial available formulations (160-177 mM-1s-1). The production of the 
nanomagnetogel is simple and easy to scale up, thus offering great technological potential. 
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Scheme 1. Schematic dextrin nanomagnetogel as dual modality imaging bioprobe (MRI and 
SPECT). 
 
